Targeted treatments for cervical cancer: a review
O Peralta-Zaragoza, VH Bermúdez-Morales… - OncoTargets and …, 2012 - Taylor & Francis
Cervical cancer is the second most common cause of cancer death in women worldwide
and the development of new diagnosis, prognostic, and treatment strategies merits special …
and the development of new diagnosis, prognostic, and treatment strategies merits special …
Prospects of molecularly-targeted therapies for cervical cancer treatment
A Carlos de Freitas… - Current drug …, 2015 - ingentaconnect.com
Cervical cancer is the third most common cancer among women worldwide and is
responsible for 275.000 deaths each year. The development of cervical cancer has been …
responsible for 275.000 deaths each year. The development of cervical cancer has been …
Human papillomavirus: current and future RNAi therapeutic strategies for cervical cancer
Human papillomaviruses (HPVs) are small DNA viruses; some oncogenic ones can cause
different types of cancer, in particular cervical cancer. HPV-associated carcinogenesis …
different types of cancer, in particular cervical cancer. HPV-associated carcinogenesis …
Emerging drugs for the treatment of cervical cancer
A Serrano-Olvera, L Cetina, J Coronel… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Worldwide, most cervical cancer (CC) patients require the use of drug therapy
either adjuvant, concurrent with radiation or palliative. Areas covered: This review briefly …
either adjuvant, concurrent with radiation or palliative. Areas covered: This review briefly …
New developments in the treatment of invasive cervical cancer
SS Im, BJ Monk - Obstetrics and Gynecology Clinics, 2002 - obgyn.theclinics.com
Worldwide, cervical cancer is one of the most common cancers in women [1]. About 450,000
women are diagnosed with cervical cancer each year around the world, and another …
women are diagnosed with cervical cancer each year around the world, and another …
[HTML][HTML] Cervical cancer therapies: Current challenges and future perspectives
Cervical cancer is the fourth most common female cancer worldwide and results in over 300
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …
Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins
AM Almeida, JA Queiroz, F Sousa, Â Sousa - Drug discovery today, 2019 - Elsevier
Highlights•Human papillomavirus (HPV) has a primordial role in the development of cervical
cancer.•Therapies currently available for cervical cancer treatment are reviewed.•The …
cancer.•Therapies currently available for cervical cancer treatment are reviewed.•The …
[HTML][HTML] Emerging biological treatments for uterine cervical carcinoma
P Vici, L Mariani, L Pizzuti, D Sergi, L Di Lauro… - Journal of …, 2014 - ncbi.nlm.nih.gov
Cervical cancer is the third most common cancer worldwide, and the development of new
diagnosis, prognostic, and treatment strategies is a major interest for public health. Cisplatin …
diagnosis, prognostic, and treatment strategies is a major interest for public health. Cisplatin …
Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer
JE Wolford, KS Tewari - Expert opinion on drug discovery, 2018 - Taylor & Francis
Introduction: Though cervical cytology, HPV DNA testing, and pre-invasive disease
management has significantly reduced the number of new diagnoses of cervical cancer …
management has significantly reduced the number of new diagnoses of cervical cancer …
Molecular approaches to cervical cancer therapy
LM Alvarez-Salas, JA DiPaolo - Current drug discovery …, 2007 - ingentaconnect.com
Cervical cancer is the second most common malignancy in women worldwide. Two HPV
strains, HPV-16 and 18, occur in the 70% of untreated cancers. Expression of viral …
strains, HPV-16 and 18, occur in the 70% of untreated cancers. Expression of viral …